Stock DRRX DURECT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus DURECT Corporation

Equities

DRRX

US2666055007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
1.31 USD +2.34% Intraday chart for DURECT Corporation +1.55% +122.03%
May. 21 DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis CI
May. 21 Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon MT

Evolution of the average Target Price on DURECT Corporation

Price target over the last 5 years

History of analyst recommendation changes

12d.Qj8t_Zl2iOSltsuDlVoYiCFD45FkJ9RpXNl7ESraTfw.LXdgss8O243kxKXV5CpBvkU2zusrF-xeDr1Deny_P4gubX7NziHjteTupA~8f6d239aa4a38021f3f6b79f1c50e112

Analyst Recommendations on DURECT Corporation

Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says MT
JonesTrading Downgrades Durect to Hold From Buy MT
HC Wainwright Downgrades Durect to Neutral From Buy MT
Cantor Fitzgerald Adjusts Price Target on Durect to $41 From $44, Keeps Overweight Rating MT
HC Wainwright Adjusts Price Target on Durect to $27 From $32, Maintains Buy Rating MT
JonesTrading Initiates Durect at Buy With $37 Price Target MT
HC Wainwright Trims Price Target on Durect to $32 From $35, Maintains Buy Rating MT
Oppenheimer Adjusts Price Target on Durect to $32 From $6 on Reverse Stock Split, Market Conditions, Maintains Outperform Rating MT
DURECT : Chardan Suspends Coverage on Durect at Buy Rating With $8 Price Target MT
DURECT : Chardan Adjusts Price Target on Durect to $8 From $7, Maintains Buy Rating MT
Berenberg NASH Day FA
DURECT Corporation : to Participate in the Berenberg NASH Day PR
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.31 USD
Average target price
6.75 USD
Spread / Average Target
+415.27%
High Price Target
8.5 USD
Spread / Highest target
+548.85%
Low Price Target
5 USD
Spread / Lowest Target
+281.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering DURECT Corporation

JonesTrading Institutional Services
HC Wainwright
Cantor Fitzgerald
Oppenheimer
Chardan

Ratings for DURECT Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DRRX Stock
  4. Consensus DURECT Corporation